Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion type Assertion NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_head.
- NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion description "[2011;11:907-15) showed that 800 mg QD raltegravir failed to meet the criteria for non-inferiority when compared with 400 mg BID RAL in antiretroviral-naive HIV-infected individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_provenance.
- NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion evidence source_evidence_literature NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_provenance.
- NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion SIO_000772 24322385 NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_provenance.
- NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion wasDerivedFrom befree-2016 NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_provenance.
- NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_assertion wasGeneratedBy ECO_0000203 NP1135225.RAYLSSHER-HEhzgZIahz_Oq8kZe1ydOTVGWBL4Bd3E9HY130_provenance.